Barclays Has Lowered Expectations for Chemours (NYSE:CC) Stock Price

Chemours (NYSE:CC - Get Free Report) had its target price decreased by analysts at Barclays from $19.00 to $16.00 in a report issued on Tuesday,Benzinga reports. The firm presently has an "equal weight" rating on the specialty chemicals company's stock. Barclays's target price would indicate a potential upside of 22.32% from the stock's previous close.

Several other equities research analysts have also commented on the stock. Mizuho upgraded shares of Chemours from a "neutral" rating to an "outperform" rating and set a $19.00 price target on the stock in a research note on Thursday, March 27th. Truist Financial began coverage on Chemours in a research report on Tuesday, January 28th. They set a "buy" rating and a $27.00 target price on the stock. BMO Capital Markets decreased their target price on Chemours from $34.00 to $27.00 and set an "outperform" rating for the company in a research report on Wednesday, February 19th. Morgan Stanley cut their price target on Chemours from $25.00 to $22.00 and set an "equal weight" rating on the stock in a research report on Monday, January 13th. Finally, The Goldman Sachs Group reduced their price objective on Chemours from $24.00 to $21.00 and set a "neutral" rating for the company in a research note on Tuesday, January 7th. Four research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $22.56.

Remove Ads

Chemours Stock Up 0.9 %

Chemours stock traded up $0.12 during midday trading on Tuesday, reaching $13.08. The company's stock had a trading volume of 4,548,007 shares, compared to its average volume of 1,736,742. The business has a 50-day simple moving average of $16.02 and a 200-day simple moving average of $18.11. The company has a market cap of $1.95 billion, a P/E ratio of 22.95 and a beta of 1.84. Chemours has a fifty-two week low of $12.65 and a fifty-two week high of $29.21. The company has a quick ratio of 0.92, a current ratio of 1.68 and a debt-to-equity ratio of 6.70.

Chemours (NYSE:CC - Get Free Report) last posted its earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.10 by $0.01. The firm had revenue of $1.36 billion during the quarter, compared to analysts' expectations of $1.37 billion. Chemours had a return on equity of 26.54% and a net margin of 1.51%. On average, research analysts expect that Chemours will post 2.03 earnings per share for the current fiscal year.

Institutional Trading of Chemours

Several hedge funds have recently made changes to their positions in CC. Charles Schwab Investment Management Inc. lifted its position in Chemours by 2.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,229,052 shares of the specialty chemicals company's stock valued at $24,974,000 after purchasing an additional 32,590 shares during the period. Erste Asset Management GmbH acquired a new stake in shares of Chemours in the 3rd quarter valued at approximately $728,000. Holocene Advisors LP boosted its stake in shares of Chemours by 1,058.1% in the third quarter. Holocene Advisors LP now owns 194,465 shares of the specialty chemicals company's stock valued at $3,952,000 after buying an additional 177,673 shares in the last quarter. HighTower Advisors LLC grew its holdings in Chemours by 10.1% during the third quarter. HighTower Advisors LLC now owns 15,020 shares of the specialty chemicals company's stock worth $300,000 after acquiring an additional 1,384 shares during the period. Finally, Jacobs Levy Equity Management Inc. acquired a new position in Chemours during the third quarter worth $2,449,000. Institutional investors and hedge funds own 76.26% of the company's stock.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.